Biotech · Private company
ZevraDenmark
Track this companyFree. Adds ZevraDenmark to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- arimoclomolPhase 3 · Niemann-Pick Disease, Type CClinicalTrials.gov · fetched Nov 12, 2026
- ArimoclomolPhase 3 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- ArimoclomolPhase 3 · Inclusion Body MyositisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension TrialPHASE3 · TERMINATED · started Sep 19, 2019ClinicalTrials.gov NCT03836716 · fetched Nov 12, 2026
- Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension TrialPHASE3 · TERMINATED · started May 20, 2019ClinicalTrials.gov NCT04049097 · fetched Nov 12, 2026
- Arimoclomol in Amyotropic Lateral SclerosisPHASE3 · COMPLETED · started Jul 31, 2018ClinicalTrials.gov NCT03491462 · fetched Nov 12, 2026
- Study of Arimoclomol in Inclusion Body Myositis (IBM)PHASE2 · COMPLETED · started Aug 16, 2017ClinicalTrials.gov NCT02753530 · fetched Nov 12, 2026
- Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type CPHASE2_PHASE3 · COMPLETED · started Jun 14, 2016ClinicalTrials.gov NCT02612129 · fetched Nov 12, 2026
- Early Access Program With Arimoclomol in US Patients With NPCAVAILABLEClinicalTrials.gov NCT04316637 · fetched Nov 12, 2026